Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gen1E Lifesciences

Request full access

Developing immunomodulators for rare and inflammatory diseases

Palo Alto, United StatesFounded 2018Biotech & Life Sciences

About Gen1E Lifesciences

GEn1E Lifesciences is a biotech company specializing in the development of selective kinase inhibitors aimed at treating inflammatory and age-related diseases. The company operates in the pharmaceutical and biotechnology market, focusing on preclinical and clinical research to bring innovative treatments to patients. Its lead program targets acute respiratory distress syndrome (ARDS), a severe lung condition often seen in critically ill patients, including those with COVID-19. GEn1E's business model involves the commercialization of proprietary compounds developed in collaboration with the University of Maryland, Baltimore. The company generates revenue through licensing agreements and partnerships with other biotech firms and research institutions. GEn1E's CEO, Dr. Ritu Lal, brings over 20 years of experience in pharmaceutical R&D, having successfully taken multiple compounds from discovery to regulatory approval. The company is backed by prominent accelerators like Y Combinator and has strong ties to the Baltimore biotech ecosystem.

Source: Dealroom company data

At a glance

Status
Operational
Employees
18
Open positions
None listed
Dealroom signal
75.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, Longevity, DT and LS, science-based

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Dec 2022 $17M $68M Undisclosed —
SEED✓Equity / VC Aug 2021 — — 10X Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Gen1E Lifesciences website traffic

Latest recorded traffic for Gen1E Lifesciences is 290 monthly website visits, up 0% over the last three months. Gen1E Lifesciences's team grew 63.6% over the past year.

Latest monthly visits290 3-month web change0% 1-year team growth+63.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Gen1E Lifesciences in the Palo Alto ecosystem

Live from Dealroom

The Gen1E Lifesciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Other known investors7 additional known investors

Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States73.3%
🇧🇷 Brazil6.7%
🇨🇦 Canada6.7%
🇮🇳 India6.7%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gen1E Lifesciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gen1E Lifesciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.